- Home
- WGSWW vs CLBK Comparison
WGSWW vs CLBK Comparison
Compare WGSWW & CLBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WGSWW
- CLBK
- Stock Information
- Founded
- WGSWW 2017
- CLBK 1927
- Country
- WGSWW United States
- CLBK United States
- Employees
- WGSWW 1000
- CLBK N/A
- Industry
- WGSWW Retail: Computer Software & Peripheral Equipment
- CLBK Savings Institutions
- Sector
- WGSWW Technology
- CLBK Finance
- Exchange
- WGSWW Nasdaq
- CLBK Nasdaq
- Market Cap
- WGSWW N/A
- CLBK N/A
- IPO Year
- WGSWW N/A
- CLBK N/A
- Fundamental
- Price
- WGSWW $0.07
- CLBK $14.14
- Analyst Decision
- WGSWW
- CLBK Hold
- Analyst Count
- WGSWW 0
- CLBK 1
- Target Price
- WGSWW N/A
- CLBK $16.00
- AVG Volume (30 Days)
- WGSWW 36.6K
- CLBK 116.6K
- Earning Date
- WGSWW 02-18-2025
- CLBK 07-30-2025
- Dividend Yield
- WGSWW N/A
- CLBK N/A
- EPS Growth
- WGSWW N/A
- CLBK N/A
- EPS
- WGSWW N/A
- CLBK N/A
- Revenue
- WGSWW $305,450,000.00
- CLBK $176,914,000.00
- Revenue This Year
- WGSWW N/A
- CLBK $31.86
- Revenue Next Year
- WGSWW N/A
- CLBK $13.37
- P/E Ratio
- WGSWW N/A
- CLBK N/A
- Revenue Growth
- WGSWW 50.79
- CLBK N/A
- 52 Week Low
- WGSWW $0.17
- CLBK $12.64
- 52 Week High
- WGSWW $0.21
- CLBK $19.28
- Technical
- Relative Strength Index (RSI)
- WGSWW N/A
- CLBK 42.35
- Support Level
- WGSWW N/A
- CLBK $14.21
- Resistance Level
- WGSWW N/A
- CLBK $14.55
- Average True Range (ATR)
- WGSWW 0.00
- CLBK 0.41
- MACD
- WGSWW 0.00
- CLBK -0.11
- Stochastic Oscillator
- WGSWW 0.00
- CLBK 7.42
About WGSWW GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.